Dennis,
Some of the numbers did sound a bit too high, but keep in mind that it was an article by the hometown newspaper of the original RAIN....like having your own conference reps at a bowl game. Generally, the info was in-line, but probably a bit exaggerated. If it created extra
interest in others wanting to learn more about it, I guess it does its job. I'd prefer more factual info, or at least opinions which can be supported by facts, too, however. Held its own back to 36 again today..unfortunately DANB not so lucky. Still no news to speak of for them either.
Thanks for the congrats on ATIS, but it is too early for that. It also is not too late if you like them, just too late to get early. Slight drop to 19 and 5/8 today, and with any market dips could get back a bit more again. However, more likely good news with probable dermagraft TC approval
11/19...slotted for FDA agenda then. The real kicker is the dermagraft though, and with approval by FDA...submitting likely in 12/96.....as early as 4-6 months after, the revenue can really start, and so could the upward movement. It has the potential to hit AMGEN like numbers of years ago.
HOwever, it's that principal thing that keeps me from buying more...hate to get the cost average up....like with RAIN. Now, if it is approved by the FDA next summer, then congrats might mean something....currently still just short-term good news in speculative area. Thanks though, big bro.
BTW, listening to me usually gets most people in trouble.
Any thoughts on where RAIN and DANB go from here?
Regards,
Marshall |
